Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 21, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 21, 2026
DirectorOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001809519-26-000008
Filed / recorded
Jan 21, 2026, 10:20 PM UTC
Added to OQRO
Oct 7, 2026, 5:51 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GoodRx Holdings, Inc.
Issuer CIK
1809519
Ticker
GDRX
Reporting person
Scott Wagner
Relationship
Director
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
Jan 21, 2026
Transaction code
M
Shares / units
31,394
Acquired / disposed
Acquired (A)
Shares owned after
216,663
Ownership form
Direct
Amendment
No
Footnotes from the filing
The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
